Literature DB >> 20353877

Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen.

Lamia Naouel Hachehouche1, Nizar Chetoui, Fawzi Aoudjit.   

Abstract

T cell migration through extracellular matrix of the tissue is an important process in the development of inflammation. However, the mechanisms regulating this process are complex and still not well defined. In this study, we show that activation of human peripheral blood T cells with anti-CD3 mAb increases the mRNA and protein levels of the discoidin domain receptor 1 (DDR1), which is known to bind to collagens. Furthermore, our findings indicate that DDR1 is involved in the migration of activated T cells in three-dimensional (3D) collagen. Indeed, the use of a DDR1 blocking molecule (DDR1:Fc) reduced the capacity of anti-CD3-activated human T cells to migrate in 3D collagen, whereas a control immunoglobulin had no effect. As a control, the DDR1:Fc molecule did not interfere with the capacity of human T cells to migrate through fibronectin. Together these results suggest that DDR1 can represent an additional receptor regulating T cell movement in the tissues and therefore can contribute to the development of inflammatory diseases. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353877     DOI: 10.1016/j.molimm.2010.02.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

1.  Loss of Discoidin Domain Receptor 1 Predisposes Mice to Periodontal Breakdown.

Authors:  M B Chavez; T N Kolli; M H Tan; C Zachariadou; C Wang; M C Embree; E J Lira Dos Santos; F H Nociti; Y Wang; D N Tatakis; G Agarwal; B L Foster
Journal:  J Dent Res       Date:  2019-10-14       Impact factor: 6.116

Review 2.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Discoidin domain receptor 1 protein is a novel modulator of megakaryocyte-collagen interactions.

Authors:  Vittorio Abbonante; Cristian Gruppi; Diana Rubel; Oliver Gross; Remigio Moratti; Alessandra Balduini
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

4.  Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.

Authors:  Hsueh-Liang Fu; Anjum Sohail; Rajeshwari R Valiathan; Benjamin D Wasinski; Malika Kumarasiri; Kiran V Mahasenan; M Margarida Bernardo; Dorota Tokmina-Roszyk; Gregg B Fields; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

5.  Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices.

Authors:  Philippe V Afonso; Colin P McCann; Senta M Kapnick; Carole A Parent
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

Review 6.  Increasing cancer permeability by photodynamic priming: from microenvironment to mechanotransduction signaling.

Authors:  Nazareth Milagros Carigga Gutierrez; Núria Pujol-Solé; Qendresa Arifi; Jean-Luc Coll; Tristan le Clainche; Mans Broekgaarden
Journal:  Cancer Metastasis Rev       Date:  2022-09-26       Impact factor: 9.237

Review 7.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

8.  Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway.

Authors:  Mohammed-Amine El Azreq; Maleck Kadiri; Marc Boisvert; Nathalie Pagé; Philippe A Tessier; Fawzi Aoudjit
Journal:  Oncotarget       Date:  2016-07-19

Review 9.  Discoidin domain receptor functions in physiological and pathological conditions.

Authors:  Birgit Leitinger
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

10.  Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease.

Authors:  Monique Kerroch; Carlo Alfieri; Aude Dorison; Jean-Jacques Boffa; Christos Chatziantoniou; Jean-Claude Dussaule
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.